205 related articles for article (PubMed ID: 26944191)
1. MnTE-2-PyP reduces prostate cancer growth and metastasis by suppressing p300 activity and p300/HIF-1/CREB binding to the promoter region of the PAI-1 gene.
Tong Q; Weaver MR; Kosmacek EA; O'Connor BP; Harmacek L; Venkataraman S; Oberley-Deegan RE
Free Radic Biol Med; 2016 May; 94():185-94. PubMed ID: 26944191
[TBL] [Abstract][Full Text] [Related]
2. MnTE-2-PyP modulates thiol oxidation in a hydrogen peroxide-mediated manner in a human prostate cancer cell.
Tong Q; Zhu Y; Galaske JW; Kosmacek EA; Chatterjee A; Dickinson BC; Oberley-Deegan RE
Free Radic Biol Med; 2016 Dec; 101():32-43. PubMed ID: 27671770
[TBL] [Abstract][Full Text] [Related]
3. MnTE-2-PyP Treatment, or NOX4 Inhibition, Protects against Radiation-Induced Damage in Mouse Primary Prostate Fibroblasts by Inhibiting the TGF-Beta 1 Signaling Pathway.
Chatterjee A; Kosmacek EA; Oberley-Deegan RE
Radiat Res; 2017 Mar; 187(3):367-381. PubMed ID: 28225655
[TBL] [Abstract][Full Text] [Related]
4. Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1α/p300 complex in a preclinical model of prostate cancer.
Reece KM; Richardson ED; Cook KM; Campbell TJ; Pisle ST; Holly AJ; Venzon DJ; Liewehr DJ; Chau CH; Price DK; Figg WD
Mol Cancer; 2014 Apr; 13():91. PubMed ID: 24775564
[TBL] [Abstract][Full Text] [Related]
5. NDRG3 lowers the metastatic potential in prostate cancer as a feedback controller of hypoxia-inducible factors.
Lee GY; Shin SH; Shin HW; Chun YS; Park JW
Exp Mol Med; 2018 May; 50(5):1-13. PubMed ID: 29760417
[TBL] [Abstract][Full Text] [Related]
6. Superoxide dismutase mimic, MnTE-2-PyP(5+) ameliorates acute and chronic proctitis following focal proton irradiation of the rat rectum.
Archambeau JO; Tovmasyan A; Pearlstein RD; Crapo JD; Batinic-Haberle I
Redox Biol; 2013; 1(1):599-607. PubMed ID: 24363995
[TBL] [Abstract][Full Text] [Related]
7. Analysis of a metalloporphyrin antioxidant mimetic (MnTE-2-PyP) as a radiomitigator: prostate tumor and immune status.
Mehrotra S; Pecaut MJ; Freeman TL; Crapo JD; Rizvi A; Luo-Owen X; Slater JM; Gridley DS
Technol Cancer Res Treat; 2012 Oct; 11(5):447-57. PubMed ID: 22475066
[TBL] [Abstract][Full Text] [Related]
8. The antioxidant, MnTE-2-PyP, prevents side-effects incurred by prostate cancer irradiation.
Oberley-Deegan RE; Steffan JJ; Rove KO; Pate KM; Weaver MW; Spasojevic I; Frederick B; Raben D; Meacham RB; Crapo JD; Koul HK
PLoS One; 2012; 7(9):e44178. PubMed ID: 22984473
[TBL] [Abstract][Full Text] [Related]
9. Effect of a metalloporphyrin antioxidant (MnTE-2-PyP) on the response of a mouse prostate cancer model to radiation.
Makinde AY; Luo-Owen X; Rizvi A; Crapo JD; Pearlstein RD; Slater JM; Gridley DS
Anticancer Res; 2009 Jan; 29(1):107-18. PubMed ID: 19331139
[TBL] [Abstract][Full Text] [Related]
10. Roles of p300 and cyclic adenosine monophosphate response element binding protein in high glucose-induced hypoxia-inducible factor 1α inactivation under hypoxic conditions.
Ding L; Yang M; Zhao T; Lv G
J Diabetes Investig; 2017 May; 8(3):277-285. PubMed ID: 27808477
[TBL] [Abstract][Full Text] [Related]
11. FOXO4 induces human plasminogen activator inhibitor-1 gene expression via an indirect mechanism by modulating HIF-1alpha and CREB levels.
Dimova EY; Samoylenko A; Kietzmann T
Antioxid Redox Signal; 2010 Aug; 13(4):413-24. PubMed ID: 20136501
[TBL] [Abstract][Full Text] [Related]
12. MnTE-2-PyP, a manganese porphyrin, reduces cytotoxicity caused by irradiation in a diabetic environment through the induction of endogenous antioxidant defenses.
Chatterjee A; Kosmacek EA; Shrishrimal S; McDonald JT; Oberley-Deegan RE
Redox Biol; 2020 Jul; 34():101542. PubMed ID: 32361681
[TBL] [Abstract][Full Text] [Related]
13. Menadione and ethacrynic acid inhibit the hypoxia-inducible factor (HIF) pathway by disrupting HIF-1α interaction with p300.
Na YR; Han KC; Park H; Yang EG
Biochem Biophys Res Commun; 2013 May; 434(4):879-84. PubMed ID: 23618863
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional regulation of plasminogen activator inhibitor-1 expression by insulin-like growth factor-1 via MAP kinases and hypoxia-inducible factor-1 in HepG2 cells.
Dimova EY; Möller U; Herzig S; Fink T; Zachar V; Ebbesen P; Kietzmann T
Thromb Haemost; 2005 Jun; 93(6):1176-84. PubMed ID: 15968405
[TBL] [Abstract][Full Text] [Related]
15. MnTE-2-PyP Attenuates TGF-
Yang Y; Zhang P; Yan R; Wang Q; Fang E; Wu H; Li S; Tan H; Zhou X; Ma X; Tang Y; Huang Y; Deng R; Liu Y; Tong S; Wang Z; Oberley-Deegan RE; Tong Q
Oxid Med Cell Longev; 2019; 2019():8639791. PubMed ID: 30931081
[TBL] [Abstract][Full Text] [Related]
16. Manganese porphyrin, MnTE-2-PyP, treatment protects the prostate from radiation-induced fibrosis (RIF) by activating the NRF2 signaling pathway and enhancing SOD2 and sirtuin activity.
Shrishrimal S; Chatterjee A; Kosmacek EA; Davis PJ; McDonald JT; Oberley-Deegan RE
Free Radic Biol Med; 2020 May; 152():255-270. PubMed ID: 32222469
[TBL] [Abstract][Full Text] [Related]
17. MnTE-2-PyP protects fibroblast mitochondria from hyperglycemia and radiation exposure.
Chatterjee A; Sakallioglu IT; Murthy D; Kosmacek EA; Singh PK; McDonald JT; Powers R; Oberley-Deegan RE
Redox Biol; 2022 Jun; 52():102301. PubMed ID: 35358851
[TBL] [Abstract][Full Text] [Related]
18. Robust rat pulmonary radioprotection by a lipophilic Mn N-alkylpyridylporphyrin, MnTnHex-2-PyP(5+).
Gauter-Fleckenstein B; Reboucas JS; Fleckenstein K; Tovmasyan A; Owzar K; Jiang C; Batinic-Haberle I; Vujaskovic Z
Redox Biol; 2014; 2():400-10. PubMed ID: 24624330
[TBL] [Abstract][Full Text] [Related]
19. Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1α interaction with cofactors p300/CBP.
Yin S; Kaluz S; Devi NS; Jabbar AA; de Noronha RG; Mun J; Zhang Z; Boreddy PR; Wang W; Wang Z; Abbruscato T; Chen Z; Olson JJ; Zhang R; Goodman MM; Nicolaou KC; Van Meir EG
Clin Cancer Res; 2012 Dec; 18(24):6623-33. PubMed ID: 22923450
[TBL] [Abstract][Full Text] [Related]
20. Early and late administration of MnTE-2-PyP5+ in mitigation and treatment of radiation-induced lung damage.
Gauter-Fleckenstein B; Fleckenstein K; Owzar K; Jiang C; Rebouças JS; Batinic-Haberle I; Vujaskovic Z
Free Radic Biol Med; 2010 Apr; 48(8):1034-43. PubMed ID: 20096348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]